PURPOSE: The Physician Global Assessment (PGA) is a key measure of psoriasis frequently used in clinical trials. A psychometric validation of a three-item (erythema, induration, and scaling) PGA scale was performed using Phase 2 data. METHODS: Confirmatory factor analysis (CFA) tested the PGA measurement model and appropriateness of equal weighting of the items. PGA test-retest reliability was assessed by estimating the intraclass correlation coefficient (ICC). Internal consistency reliability was gauged by calculating Cronbach's coefficient α (CCα). Clinically important difference (CID) was defined using the repeated measures model to estimate the relationship between PGA and Patient Global Assessment (PtGA). Known-group, convergent, and divergent validity for the PGA were also assessed. RESULTS:197 patients with psoriasis were randomized to tofacitinib 2, 5, 15 mg twice daily, or placebo. CFA demonstrated that the PGA measurement model fitted the data using equal weighting of the PGA items. The PGA scale demonstrated good test-retest reliability (ICC > 0.7) and internal consistency reliability (CCα > 0.8). The CID for PGA was estimated at 0.52 (95 % confidence interval: 0.47, 0.56). A robust monotonic relationship between PGA and Psoriasis Area and Severity Index (PASI) data substantiated known-group validity. Relatively high correlations of PGA with PASI and PtGA data (all correlations >0.5 except at baseline) supported convergent validity; relatively low correlations of PGA with the Pain/Discomfort Assessment and the Ocular Comfort Index supported divergent validity. CONCLUSIONS: The three-item PGA scale has sound psychometric properties with respect to reliability and validity, with equal weighting of the items being appropriate.
RCT Entities:
PURPOSE: The Physician Global Assessment (PGA) is a key measure of psoriasis frequently used in clinical trials. A psychometric validation of a three-item (erythema, induration, and scaling) PGA scale was performed using Phase 2 data. METHODS: Confirmatory factor analysis (CFA) tested the PGA measurement model and appropriateness of equal weighting of the items. PGA test-retest reliability was assessed by estimating the intraclass correlation coefficient (ICC). Internal consistency reliability was gauged by calculating Cronbach's coefficient α (CCα). Clinically important difference (CID) was defined using the repeated measures model to estimate the relationship between PGA and Patient Global Assessment (PtGA). Known-group, convergent, and divergent validity for the PGA were also assessed. RESULTS: 197 patients with psoriasis were randomized to tofacitinib 2, 5, 15 mg twice daily, or placebo. CFA demonstrated that the PGA measurement model fitted the data using equal weighting of the PGA items. The PGA scale demonstrated good test-retest reliability (ICC > 0.7) and internal consistency reliability (CCα > 0.8). The CID for PGA was estimated at 0.52 (95 % confidence interval: 0.47, 0.56). A robust monotonic relationship between PGA and Psoriasis Area and Severity Index (PASI) data substantiated known-group validity. Relatively high correlations of PGA with PASI and PtGA data (all correlations >0.5 except at baseline) supported convergent validity; relatively low correlations of PGA with the Pain/Discomfort Assessment and the Ocular Comfort Index supported divergent validity. CONCLUSIONS: The three-item PGA scale has sound psychometric properties with respect to reliability and validity, with equal weighting of the items being appropriate.
Authors: Jeff A Sloan; Neil Aaronson; Joseph C Cappelleri; Diane L Fairclough; Claudette Varricchio Journal: Mayo Clin Proc Date: 2002-05 Impact factor: 7.616
Authors: J Berth-Jones; K Grotzinger; C Rainville; B Pham; J Huang; S Daly; M Herdman; P Firth; K Hotchkiss Journal: Br J Dermatol Date: 2006-10 Impact factor: 9.302
Authors: John P Mulhall; Irwin Goldstein; Andrew G Bushmakin; Joseph C Cappelleri; Kyle Hvidsten Journal: J Sex Med Date: 2007-09-21 Impact factor: 3.802
Authors: Mark Lebwohl; Stephen Tyring; Michael Bukhalo; Javier Alonso-Llamazares; Martin Olesen; David Lowson; Paul Yamauchi Journal: J Clin Aesthet Dermatol Date: 2016-02-01
Authors: Karen Regina Rosso Schons; André Avelino Costa Beber; Maristela de Oliveira Beck; Odirlei André Monticielo Journal: An Bras Dermatol Date: 2015-06-01 Impact factor: 1.896
Authors: Kim A Papp; Robert Bissonnette; Melinda Gooderham; Steven R Feldman; Lars Iversen; Jennifer Soung; Zoe Draelos; Carla Mamolo; Vivek Purohit; Cunshan Wang; William C Ports Journal: BMC Dermatol Date: 2016-10-03
Authors: John Koo; Stephen Tyring; William P Werschler; Suzanne Bruce; Martin Olesen; John Villumsen; Jerry Bagel Journal: J Dermatolog Treat Date: 2015-10-07 Impact factor: 3.359